ALEXANDRIA, Va., Dec. 2 -- United States Patent no. 12,485,093, issued on Dec. 2, was assigned to DERMOPARTNERS S.L. (Valencia, Spain).
"Composition for use as an antiviral in the form of nasal drops and in nebulisers" was invented by Gabriel Serrano Sanmiguel (Valencia, Spain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention relates to aqueous solutions containing a combination of lactoferrin with lactoperoxidase or with povidone iodine, encapsulated in liposomes, as active ingredients together with other components for use as nasal drops and nebulizers in combination with a mouth and face spray with antiviral, antiseptic and anti-inflammatory effects."
The patent was filed on Feb. 1, 2021, unde...